Methods of screening for ulcerative colitis by detecting an interleukin-1 receptor antagonist polymorphism
CA 2242493 A1 · Owner: Rotter, Jerome I. · Inventors: Yang, Huiying; Pizarro, Theresa; Cominelli, Fabio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel, differential association between allele 2 of the variable number of tandem repeats polymorphism at intron 2 of the human IL-1 receptor antagonist gene and ulcerative colitis in humans of Jewish ancestry has been discovered. In accordance with the present invention there is provided methods of , screening for ulcerative colitis in human subjects of Jewish ancestry comprising detecing the presence or absence of nucleic acid of the subject encoding allele 2 of the variable number of tandem repeats polymorphism at intron 2 of the human IL-1 receptor antagonist gene wherein the presence of , nucleic acid encoding allele 2 is indicative of ulcerative colitis. Kits useful for …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 8, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 8, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 8, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.